08 Sep 2022

Neurosoft Bioelectronics selected as one of the TOP 100 Swiss Startups

Neurosoft Bioelectronics was ranked among the top 10 in the Medtech field for 2022.

We are extremely honored to have been selected as one of the TOP 100 Swiss Startups of 2022 during the event organized by Venturelab. Every year a panel of leading investors and startup experts determine the final ranking from more than 1'000 young Swiss companies.

This is a great acknowledgment of our efforts and progress over the past few years to bring a revolutionary technology to patients and address some of the most devastating neurological disorders, by improving the way we interface with the human brain.

We would like to thank all our network and partners for their support, and a big thank you to the amazing team at Neurosoft Bioelectronics for all the hard work.

Read more about the Top 100 Swiss Startups event here.

Neurosoft Bioelectronics Receives ISO 13485 Certification for Quality Management System

Neurosoft Bioelectronics adds experts in Neuromodulation & Tinnitus to its Advisory Board